1. Home
  2. RCKY vs ALXO Comparison

RCKY vs ALXO Comparison

Compare RCKY & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$33.49

Market Cap

273.7M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$2.05

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKY
ALXO
Founded
1932
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
240.8M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RCKY
ALXO
Price
$33.49
$2.05
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$40.00
$3.50
AVG Volume (30 Days)
68.7K
952.5K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
1.71%
N/A
EPS Growth
94.74
26.36
EPS
0.17
N/A
Revenue
$270,408,000.00
N/A
Revenue This Year
$8.12
N/A
Revenue Next Year
$4.90
N/A
P/E Ratio
$195.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.28
$0.41
52 Week High
$48.70
$2.66

Technical Indicators

Market Signals
Indicator
RCKY
ALXO
Relative Strength Index (RSI) 32.98 58.24
Support Level $31.86 $1.99
Resistance Level $34.36 $2.30
Average True Range (ATR) 2.01 0.17
MACD -0.57 0.04
Stochastic Oscillator 14.13 77.95

Price Performance

Historical Comparison
RCKY
ALXO

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: